APN 201905220040A
Cautionary announcement
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number 1985/0002935/06
Share code: APN
ISIN: ZAE000066692
("Aspen" or "the Company")
CAUTIONARY ANNOUNCEMENT
Further to the communication in Aspen's interim results announcement made
on 7 March 2019 that the Company had embarked on a strategic review of its
European and South African Commercial Pharmaceuticals businesses,
shareholders are advised that Aspen is currently engaged in discussions with
a potential partner in Europe.
Shareholders are advised to exercise caution when dealing in the Company's
securities.
Durban
22 May 2019
Sponsor
Investec Bank Limited
Date: 22/05/2019 02:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
